Combination of anti-hiv reverse transcriptase and protease...

Details Combination of anti-hiv reverse transcriptase and protease... Combination of anti-hiv reverse transcriptase and protease...

A - Human Necessities

61

K

A61K 31/427 (2006.01) A61K 31/343 (2006.01) A61K 31/7076 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2572551

The invention relates to an anti-HIV combination comprising (i) tenofovir or its disoproxil fumarate derivative; (ii) ritonavir; and (iii) TMC 114, useful for the treatment or prevention of HIV infections. It further relates to pharmaceutical formulations containing such combinations.

L'invention concerne une combinaison anti-VIH comprenant (i) du ténofovir ou son dérivé fumarate de disoproxil; (ii) du ritonavir; et (iii) du TMC 114, utile dans le traitement ou la prévention d'infections par le VIH. L'invention concerne également des formulations pharmaceutiques contenant ces combinaisons.

Affiliated with

Also associated with

Rating

Combination of anti-hiv reverse transcriptase and protease... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of anti-hiv reverse transcriptase and protease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of anti-hiv reverse transcriptase and protease... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1687405